Cutera delists from Nasdaq as Cutera stock shifts to OTC Markets

Published on 10/02/2026 at 15:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Investments fell 19.63 percent to USD 19.85 million in 2026. For Cutera stock, PP&E per employee fell 11.03 percent to USD 105,883.67.

CUTR, US2321091082, Illustration mit AI erstellt.

Cutera Inc. (US2321091082) left Nasdaq after announcing a voluntary delisting on March 10, 2025, and Cutera stock is now listed on OTC Markets under the symbol CUTRQ, according to Investing.com. The shift changes the trading setting, while the company remains associated with aesthetic and medical laser technology.

OTC listing changes the stock context

The OTC listing is identified directly on the Cutera quote page, which also confirms the CUTRQ symbol and the US2321091082 ISIN. The page describes Cutera Inc. as an OTC Markets security rather than a Nasdaq listing, giving investors a clear distinction between the former exchange identity and the current quotation venue.

The corporate transition is important because exchange status and reporting visibility shape how market participants follow a security. Cutera's investor-relations website posted a Vendor Code of Conduct updated August 18, 2026, showing that the company continues to maintain formal operating policies for suppliers.

Liquidity measure falls 19.63 percent

Short-term investments stood at USD 19.85 million in 2026, down from USD 24.70 million in 2025, a decline of 19.63 percent, according to Eulerpool on September 21, 2026. That comparison places the balance-sheet measure in a dated historical sequence rather than presenting it as a new quarterly result.

Eulerpool also reports PP&E per employee of USD 105,883.67 in 2026 versus USD 119,015.66 in 2025, a decrease of 11.03 percent, on its Cutera metric page. The two measures point to a smaller liquid-investment base and lower property, plant and equipment per employee in the stated periods.

Aesthetic technology remains central

Cutera's product footprint includes more than 20 devices covering skin rejuvenation, body contouring, hair removal, vascular and pigmented lesions, scar treatment and tattoo removal, according to Eulerpool. The Aesthetic Index lists Cutera as the owner of the truFlex device and records FDA clearance references K251594 and K212866 reviewed in September 2026, according to The Aesthetic Index.

Company and listing details

Cutera Inc. is identified by ISIN US2321091082 and ticker CUTRQ. Its operating profile centers on aesthetic and medical laser systems, while the dated financial indicators show the balance-sheet and asset-per-employee comparisons described above.